Author correction to‘Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA'[Acta Pharmaceutica Sinica B 13(2023)2585-2600]
摘要
The authors regret that one author was missed in the author list when preparing the manuscript,while the foundation to him was mentioned in the section of Acknowledgments.Dr.Qinjie Weng should be added to the author list because of his contribution in animal study and his foundation help us to complete this study.The authors sincerely apologize for any inconvenience caused to the journal and readers.
-
1Wenxin Zhang,Xiaohui Pan,Yanjun Xu,Hongjie Guo,Mingming Zheng,Xi Chen,Honghai Wu,Fengming Luan,Qiaojun He,Ling Ding,Bo Yang.Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA[J].Acta Pharmaceutica Sinica B,2023,13(6):2585-2600.
-
2刘洪超,魏志豪,史康克,张雨,李佳琼,王冬梅.RPL3可作为低级别胶质瘤的预后标志物且与免疫细胞浸润相关[J].联勤军事医学,2023,37(7):585-591.
-
3周泽军,谢海燕,张宇,石文,夏宁.安罗替尼联合抗程序性死亡受体-1抑制剂抑制肺腺癌的可能机制探讨[J].实用临床医药杂志,2023,27(17):51-56. 被引量：1
